VivoSeq
Other

Meconium Aspiration Syndrome

5

Pipeline Programs↗

1

Active Trials↗

4

Companies Involved↗

Meconium Aspiration Syndrome is an early-stage landscape with 5 programs across 4 companies. The most active players are Kaken Pharmaceutical, Lees Hk, Viatris Specialty LLC. 1 therapy is approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

6/100

Mech. Concentration

33/100

Completion Rate

83/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

K

Kaken Pharmaceutical

1 program

Phase 2L

Lees Hk

1 program

Phase 3V

Viatris Specialty LLC

1 program

ApprovedW

Windtree Therapeutics

0 programs

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

7

clinical trials

Completed5 · 71%
Terminated1 · 14%
Not yet recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

CAffeine Use in Prolonged Oxygen Use in meConium aspIration Syndrome in Neonatal Outcomes (CAPUCINO)
Not yet recruiting·UUniversity of Alberta·Phase 2·NCT06972108·20 enrolled
Efficacy of Dexamethasone in Treatment of Meconium Aspiration Syndrome
Completed·SServices Institute of Medical Sciences, Pakistan·N/A·NCT05517499·120 enrolled
Comparison Of Surfactant Lung Lavage With Standard Care In The Treatment Of Meconium Aspiration Syndrome
Completed·LLady Hardinge Medical College·N/A·NCT01310621·60 enrolled
Early Bolus Surfactant Replacement Therapy Versus Standard Care in Term Neonates With Meconium Aspiration Syndrome
Completed·LLady Hardinge Medical College·N/A·NCT06090981·60 enrolled
Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns
Completed·SSir Takhtasinhji General Hospital·Phase 4·NCT01757782·96 enrolled
Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome
Completed·ZZekai Tahir Burak Women's Health Research and Education Hospital·Phase 4·NCT02041546·30 enrolled
Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
Terminated·WWindtree Therapeutics·Phase 3·NCT00004500·69 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)